Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Röhnert

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Clinical Radiology|June 14, 2021
Whole-body R2∗ mapping to quantify tissue iron in iron storage organs: reference values and a genotypeM L Kromrey, A Röhnert, S Blum, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|August 28, 2022
Identification of critical hemodilution by artificial intelligence in bone marrow assessed for minimal residual disease analysis in acute myeloid leukemia: The Cinderella methodJoerg Hoffmann, Michael C Thrun, Maximilian A Röhnert, et al.
Clinical Lymphoma, Myeloma & Leukemia|September 16, 2025
Prognostic Value of Multicolor-Flow Cytometric Measurable Residual Disease Detection in Acute Myeloid Leukemia Prior to Allogeneic Hematopoietic Cell Transplantation: Potential Role of HLA-DRMaximilian A Röhnert, Chiara Löffler, Michael Kramer, et al.
Leukemia|July 19, 2022
Reproducible measurable residual disease detection by multiparametric flow cytometry in acute myeloid leukemiaMaximilian A Röhnert, Michael Kramer, Jonas Schadt, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Clinical Radiology|June 14, 2021
Whole-body R2∗ mapping to quantify tissue iron in iron storage organs: reference values and a genotypeM L Kromrey, A Röhnert, S Blum, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|August 28, 2022
Identification of critical hemodilution by artificial intelligence in bone marrow assessed for minimal residual disease analysis in acute myeloid leukemia: The Cinderella methodJoerg Hoffmann, Michael C Thrun, Maximilian A Röhnert, et al.
Clinical Lymphoma, Myeloma & Leukemia|September 16, 2025
Prognostic Value of Multicolor-Flow Cytometric Measurable Residual Disease Detection in Acute Myeloid Leukemia Prior to Allogeneic Hematopoietic Cell Transplantation: Potential Role of HLA-DRMaximilian A Röhnert, Chiara Löffler, Michael Kramer, et al.
Leukemia|July 19, 2022
Reproducible measurable residual disease detection by multiparametric flow cytometry in acute myeloid leukemiaMaximilian A Röhnert, Michael Kramer, Jonas Schadt, et al.
Pageof 1